Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions

The journey toward a viable malaria vaccine, initiated in 1965, reached a major milestone in 2021 with the WHO’s endorsement of RTS,S/AS01, a recombinant protein-based malaria vaccine. This progress continued with the 2023 approval of the R21/Matrix-M vaccine, which is more cost-effective, more pote...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajesh Perumbilavil Kaithamanakallam, Tirath Patel, Bharati Balachandran, Neville Fernandez, Joseph Jillwin, Dharambir Kashyap, Aparna Shivaprasad, Uttam Udayan, Pragnesh Kalyandrug, Aakanksha Aakanksha, Prasanna Honnavar
Format: Article
Language:English
Published: MDPI AG 2025-05-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/6/1270
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849433379520380928
author Rajesh Perumbilavil Kaithamanakallam
Tirath Patel
Bharati Balachandran
Neville Fernandez
Joseph Jillwin
Dharambir Kashyap
Aparna Shivaprasad
Uttam Udayan
Pragnesh Kalyandrug
Aakanksha Aakanksha
Prasanna Honnavar
author_facet Rajesh Perumbilavil Kaithamanakallam
Tirath Patel
Bharati Balachandran
Neville Fernandez
Joseph Jillwin
Dharambir Kashyap
Aparna Shivaprasad
Uttam Udayan
Pragnesh Kalyandrug
Aakanksha Aakanksha
Prasanna Honnavar
author_sort Rajesh Perumbilavil Kaithamanakallam
collection DOAJ
description The journey toward a viable malaria vaccine, initiated in 1965, reached a major milestone in 2021 with the WHO’s endorsement of RTS,S/AS01, a recombinant protein-based malaria vaccine. This progress continued with the 2023 approval of the R21/Matrix-M vaccine, which is more cost-effective, more potent due it is higher protein content, and easier to manufacture. Though these achievements signal hope, malaria’s intricate life cycle and its prevalence in underprivileged regions make vaccine development and equitable distribution challenging. This review explains the lifecycle of malaria and explores the evolution of various treatment strategies aimed at reducing malaria-related mortality. This scoping review aims to provide a comprehensive overview of malaria vaccines, examining their development, efficacy, safety, and implementation challenges. Using a structured literature search across PubMed, Web of Science, and Scopus, we identified key themes related to malaria vaccines trials, policy implications, and future research needs. Peer-reviewed publications on PubMed, Scopus, and Web of Science from 1970 to 2024 were searched without any limitations. Search and Boolean search terms were modified to include terms like “malaria vaccines”, “malaria vaccination”, “malaria immunisation”, “malaria immunisation AND malaria-endemic countries”, “malaria endemic low-income countries AND malaria control”, “malaria public health control”, “malaria chemoprophylaxis AND early diagnosis of malaria”, “screening for malaria”, and “laboratory diagnosis of malaria in endemic countries” in order to find pertinent studies. Preliminary insights suggest that although vaccines are crucial, comprehensive strategies involving health education, hygiene, and timely medical intervention remain essential to malaria control.
format Article
id doaj-art-8bb60c830bf4493792aa043a468f8340
institution Kabale University
issn 2227-9059
language English
publishDate 2025-05-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-8bb60c830bf4493792aa043a468f83402025-08-20T03:27:05ZengMDPI AGBiomedicines2227-90592025-05-01136127010.3390/biomedicines13061270Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future DirectionsRajesh Perumbilavil Kaithamanakallam0Tirath Patel1Bharati Balachandran2Neville Fernandez3Joseph Jillwin4Dharambir Kashyap5Aparna Shivaprasad6Uttam Udayan7Pragnesh Kalyandrug8Aakanksha Aakanksha9Prasanna Honnavar10Department of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaBasic Medical Science, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaDepartment of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaDepartment of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaDepartment of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaBrown Center for Immunotherapy, Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN 46202, USADepartment of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaDepartment of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaBasic Medical Science, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaInternal Medicine, Tbilisi State Medical University, 33 Vazha Pshavela Avenue, Tbilisi 0159, GeorgiaDepartment of Microbiology and Immunology, American University of Antigua College of Medicine, St. Johns 1451, Antigua and BarbudaThe journey toward a viable malaria vaccine, initiated in 1965, reached a major milestone in 2021 with the WHO’s endorsement of RTS,S/AS01, a recombinant protein-based malaria vaccine. This progress continued with the 2023 approval of the R21/Matrix-M vaccine, which is more cost-effective, more potent due it is higher protein content, and easier to manufacture. Though these achievements signal hope, malaria’s intricate life cycle and its prevalence in underprivileged regions make vaccine development and equitable distribution challenging. This review explains the lifecycle of malaria and explores the evolution of various treatment strategies aimed at reducing malaria-related mortality. This scoping review aims to provide a comprehensive overview of malaria vaccines, examining their development, efficacy, safety, and implementation challenges. Using a structured literature search across PubMed, Web of Science, and Scopus, we identified key themes related to malaria vaccines trials, policy implications, and future research needs. Peer-reviewed publications on PubMed, Scopus, and Web of Science from 1970 to 2024 were searched without any limitations. Search and Boolean search terms were modified to include terms like “malaria vaccines”, “malaria vaccination”, “malaria immunisation”, “malaria immunisation AND malaria-endemic countries”, “malaria endemic low-income countries AND malaria control”, “malaria public health control”, “malaria chemoprophylaxis AND early diagnosis of malaria”, “screening for malaria”, and “laboratory diagnosis of malaria in endemic countries” in order to find pertinent studies. Preliminary insights suggest that although vaccines are crucial, comprehensive strategies involving health education, hygiene, and timely medical intervention remain essential to malaria control.https://www.mdpi.com/2227-9059/13/6/1270malaria vaccinesmalaria prophylaxismalaria endemicityglobal health equityvaccine efficacy and implementation
spellingShingle Rajesh Perumbilavil Kaithamanakallam
Tirath Patel
Bharati Balachandran
Neville Fernandez
Joseph Jillwin
Dharambir Kashyap
Aparna Shivaprasad
Uttam Udayan
Pragnesh Kalyandrug
Aakanksha Aakanksha
Prasanna Honnavar
Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions
Biomedicines
malaria vaccines
malaria prophylaxis
malaria endemicity
global health equity
vaccine efficacy and implementation
title Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions
title_full Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions
title_fullStr Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions
title_full_unstemmed Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions
title_short Malaria Vaccines and Global Equity: A Scoping Review of Current Progress and Future Directions
title_sort malaria vaccines and global equity a scoping review of current progress and future directions
topic malaria vaccines
malaria prophylaxis
malaria endemicity
global health equity
vaccine efficacy and implementation
url https://www.mdpi.com/2227-9059/13/6/1270
work_keys_str_mv AT rajeshperumbilavilkaithamanakallam malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT tirathpatel malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT bharatibalachandran malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT nevillefernandez malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT josephjillwin malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT dharambirkashyap malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT aparnashivaprasad malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT uttamudayan malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT pragneshkalyandrug malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT aakankshaaakanksha malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections
AT prasannahonnavar malariavaccinesandglobalequityascopingreviewofcurrentprogressandfuturedirections